IMMUNOSIGN
LIVE

Serial Number

79214190

Owner

HalioDx

Attorney

Douglas R. Wolf

Filing Date

Jan 20, 2017

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOSIGN Trademark

Serial Number: 79214190 • Registration: 5572566

IMMUNOSIGN is a trademark filed by HalioDx on January 20, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HalioDx (6 trademarks)

163 Avenue de Luminy,
F-13288 Marseille Cédex 09 , FR

Entity Type: 34

Veracyte

Parc Scientifique de Luminy,
Marseille F-13288 , FR

Entity Type: 34

Trademark Details

Filing Date

January 20, 2017

Registration Date

October 2, 2018

Published for Opposition

July 17, 2018

Goods & Services

[ medical apparatus and instruments for providing information on diagnostics or identification of biological systems, namely, gene expression analysis and markers detection devices, medical testing devices and diagnostic apparatus for detecting, analyzing or assessing a cancer, tumor or equivalent medical condition; medical instruments for cell detection in the context of a cancer, tumor or equivalent medical condition ]

[ Software for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition, in the field of biology; application software in the nature of a mobile application for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition in the field of biology ]

[ Pharmaceutical products being chemical or biological preparations for medical and pharmaceutical use for use in vitro testing, for use in the clinical diagnostic, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostic or identification of biological systems; biological reagents for pharmaceutical use for providing information on diagnostics or identification of biological systems ]

Medical analysis services; medical assistance; health services; medical therapeutic services; medical diagnostics, diagnostics in the field of medicine; genetic analysis services for medical purposes, namely, analysis of a medical disorder, tumor, cancer or equivalent medical condition

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 10, 2026 INPS
INVALIDATION PROCESSED
Feb 10, 2026 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 26, 2025 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 26, 2024 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 26, 2024 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 26, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
May 22, 2024 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 2, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2022 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 1, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 15, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 14, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 2, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 2, 2018 R.PR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jul 17, 2018 CORR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 17, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jul 14, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 27, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 27, 2018 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 8, 2018 PREV
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2018 CRFA
CORRECTION TRANSACTION RECEIVED FROM IB
Jun 8, 2018 CRCV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 5, 2018 GNRN
NON-FINAL ACTION E-MAILED
Apr 5, 2018 GNRT
NON-FINAL ACTION WRITTEN
Apr 5, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2018 CRFA
ASSIGNED TO LIE
Feb 23, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2018 REAP
REFUSAL PROCESSED BY IB
Sep 15, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 25, 2017 RFCS
REFUSAL PROCESSED BY MPU
Aug 25, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 24, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 23, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 22, 2017 MAFR
ASSIGNED TO EXAMINER
Aug 16, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 10, 2017 REPR